MOH

Molina Healthcare, Inc. NYSE

Healthcare ·Medical - Healthcare Plans ·US · molinahealthcare.com

$195.53

Mkt Cap $10.2B

52w Low $121.06 35.1% of range 52w High $333.00

50d MA $150.85 200d MA $164.59

P/E (TTM) 21.6x

EV/EBITDA 8.7x

P/B 2.4x

Debt/Equity 1.0x

ROE 4.6%

P/FCF -13.9x

RSI (14) —

ATR (14) —

Beta 0.55

50d MA $150.85

200d MA $164.59

Avg Volume 1.9M

About

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and othe…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 22, 2026	AMC	1.57	2.35	+49.7%	153.00	+7.7%	+14.2%	+15.0%	+17.1%	+21.2%	+28.4%	—
Feb 5, 2026	AMC	0.43	-2.75	-739.5%	176.84	-28.8%	-25.5%	-27.9%	-29.1%	-30.6%	-28.3%	—
Oct 22, 2025	AMC	3.97	1.84	-53.7%	195.13	-19.5%	-17.5%	-16.3%	-16.9%	-16.5%	-17.9%	—
Jul 23, 2025	AMC	5.62	5.48	-2.5%	190.25	-9.0%	-16.8%	-13.3%	-13.7%	-15.3%	-15.9%	—
Apr 23, 2025	AMC	5.97	6.08	+1.8%	332.00	+0.4%	-5.5%	-5.3%	-3.6%	-3.7%	-1.5%	—
Feb 5, 2025	AMC	5.74	5.05	-12.0%	317.01	-9.4%	-10.1%	-10.4%	-9.6%	-13.9%	-15.9%	—
Oct 23, 2024	AMC	5.81	6.01	+3.4%	275.00	+18.2%	+17.7%	+18.4%	+14.6%	+17.5%	+17.9%	—
Jul 24, 2024	AMC	5.50	5.86	+6.5%	288.72	+10.1%	+12.3%	+16.2%	+15.3%	+21.5%	+18.2%	—
Apr 24, 2024	AMC	5.59	5.73	+2.5%	367.41	-4.1%	-4.1%	-6.9%	-6.4%	-6.9%	-7.8%	—
Feb 7, 2024	AMC	4.35	4.38	+0.7%	362.10	+0.8%	+5.4%	+7.3%	+8.4%	+8.9%	+10.5%	—
Oct 25, 2023	AMC	4.88	5.05	+3.5%	336.45	-9.3%	-1.5%	-0.1%	-2.5%	-1.0%	+0.1%	—
Jul 26, 2023	AMC	5.10	5.65	+10.8%	311.17	+2.1%	-1.2%	-3.1%	-2.1%	-2.9%	-2.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 29	BofA Securities	Upgrade	Underperform → Buy	$250	$185.46	$189.96	+2.4%	+5.9%	+4.9%	+3.9%	—	—
Apr 27	Truist	Maintains	Hold → Hold	—	$175.94	$177.96	+1.1%	+1.9%	+5.4%	+11.7%	+10.6%	+9.5%
Apr 27	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$175.94	$177.96	+1.1%	+1.9%	+5.4%	+11.7%	+10.6%	+9.5%
Apr 24	UBS	Maintains	Neutral → Neutral	—	$174.70	$175.12	+0.2%	+0.7%	+2.6%	+6.2%	+12.5%	+11.4%
Apr 24	Barclays	Maintains	Underweight → Underweight	—	$174.70	$175.12	+0.2%	+0.7%	+2.6%	+6.2%	+12.5%	+11.4%
Apr 24	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$174.70	$175.12	+0.2%	+0.7%	+2.6%	+6.2%	+12.5%	+11.4%
Mar 12	UBS	Maintains	Neutral → Neutral	—	$146.80	$145.24	-1.1%	+1.7%	+1.6%	-0.2%	-1.9%	+1.2%
Mar 12	Mizuho	Maintains	Outperform → Outperform	—	$146.80	$145.24	-1.1%	+1.7%	+1.6%	-0.2%	-1.9%	+1.2%
Mar 4	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$144.81	$144.00	-0.6%	+3.6%	+2.0%	-0.2%	+0.8%	-2.4%
Feb 20	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$148.24	$145.93	-1.6%	+1.9%	+5.4%	+0.0%	-1.8%	-1.3%
Feb 17	Truist	Maintains	Hold → Hold	—	$135.35	$135.07	-0.2%	+0.2%	+5.4%	+9.5%	+11.6%	+15.4%
Feb 12	Goldman Sachs	Maintains	Neutral → Neutral	—	$122.65	$123.00	+0.3%	+3.3%	+10.4%	+10.6%	+16.3%	+20.9%
Feb 10	Barclays	Maintains	Underweight → Underweight	—	$127.53	$128.00	+0.4%	-1.6%	-3.8%	-0.6%	+6.1%	+6.4%
Feb 9	TD Cowen	Maintains	Hold → Hold	—	$131.72	$132.00	+0.2%	-3.2%	-4.8%	-6.9%	-3.8%	+2.8%
Feb 9	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$131.72	$132.00	+0.2%	-3.2%	-4.8%	-6.9%	-3.8%	+2.8%
Jan 7	Wells Fargo	Maintains	Overweight → Overweight	—	$184.73	$185.53	+0.4%	-4.5%	-0.7%	-1.7%	-1.6%	-2.1%
Jan 5	Barclays	Maintains	Underweight → Underweight	—	$178.46	$180.25	+1.0%	+2.4%	+3.5%	-1.2%	+2.8%	+1.7%
Nov 12	Wells Fargo	Maintains	Overweight → Overweight	—	$143.52	$142.64	-0.6%	-1.7%	-3.5%	-4.2%	-4.7%	-1.6%
Oct 24	Goldman Sachs	Maintains	Neutral → Neutral	—	$161.00	$160.40	-0.4%	+1.4%	+0.7%	+1.1%	-0.4%	-6.1%
Oct 24	Barclays	Downgrade	Equal Weight → Underweight	—	$161.00	$160.40	-0.4%	+1.4%	+0.7%	+1.1%	-0.4%	-6.1%
Oct 24	UBS	Maintains	Neutral → Neutral	—	$161.00	$160.40	-0.4%	+1.4%	+0.7%	+1.1%	-0.4%	-6.1%
Oct 24	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$161.00	$160.40	-0.4%	+1.4%	+0.7%	+1.1%	-0.4%	-6.1%
Oct 14	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$194.27	$192.32	-1.0%	+0.3%	-1.0%	-2.9%	-0.8%	+1.7%
Oct 7	Wells Fargo	Maintains	Overweight → Overweight	—	$200.57	$203.86	+1.6%	+1.3%	+1.2%	-0.1%	-3.3%	-3.1%
Sep 5	Bernstein	Maintains	Outperform → Outperform	—	$170.83	$170.73	-0.1%	+2.2%	+2.8%	+6.3%	+4.9%	+10.3%
Sep 4	Barclays	Maintains	Equal Weight → Equal Weight	—	$177.04	$170.00	-4.0%	-3.5%	-1.4%	-0.8%	+2.5%	+1.2%
Aug 26	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$175.17	$174.43	-0.4%	-0.2%	+0.5%	-0.3%	+3.2%	+4.6%
Aug 15	Wells Fargo	Maintains	Overweight → Overweight	—	$159.63	$166.51	+4.3%	+4.9%	+6.0%	+8.9%	+8.8%	+8.3%
Jul 29	JP Morgan	Maintains	Neutral → Neutral	—	$164.19	$160.28	-2.4%	-1.9%	-2.6%	-3.8%	-5.5%	-3.7%
Jul 25	Baird	Maintains	Neutral → Neutral	—	$158.22	$157.80	-0.3%	+4.3%	+3.8%	+1.8%	+1.1%	-0.2%
Jul 25	Truist	Downgrade	Buy → Hold	—	$158.22	$157.80	-0.3%	+4.3%	+3.8%	+1.8%	+1.1%	-0.2%
Jul 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$158.22	$157.80	-0.3%	+4.3%	+3.8%	+1.8%	+1.1%	-0.2%
Jul 25	Cantor Fitzgerald	Downgrade	Overweight → Neutral	—	$158.22	$157.80	-0.3%	+4.3%	+3.8%	+1.8%	+1.1%	-0.2%
Jul 25	UBS	Maintains	Neutral → Neutral	—	$158.22	$157.80	-0.3%	+4.3%	+3.8%	+1.8%	+1.1%	-0.2%
Jul 23	Wells Fargo	Maintains	Overweight → Overweight	—	$180.64	$182.71	+1.1%	+5.3%	-12.4%	-8.6%	-9.1%	-10.8%
Jul 16	Truist	Maintains	Buy → Buy	—	$214.61	$213.64	-0.5%	+0.7%	-4.8%	-14.7%	-17.8%	-15.8%
Jul 11	Mizuho	Maintains	Outperform → Outperform	—	$228.58	$226.50	-0.9%	-3.1%	-4.2%	-6.1%	-5.5%	-10.6%
Jul 10	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$237.22	$233.00	-1.8%	-3.6%	-6.6%	-7.7%	-9.5%	-8.9%
Jun 9	Barclays	Maintains	Equal Weight → Equal Weight	—	$296.88	$299.99	+1.0%	+0.0%	-0.4%	-0.8%	-1.1%	+0.4%
Jun 2	Barclays	Maintains	Equal Weight → Equal Weight	—	$305.04	$301.98	-1.0%	-2.5%	-3.8%	-4.1%	-3.8%	-2.7%
Apr 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$313.81	$314.04	+0.1%	+0.2%	+2.0%	+1.9%	+4.2%	-0.2%
Apr 15	Baird	Downgrade	Outperform → Neutral	—	$348.57	$346.83	-0.5%	-3.7%	-4.6%	-7.6%	-13.3%	-7.9%
Apr 11	Truist	Maintains	Buy → Buy	—	$342.68	$340.71	-0.6%	+0.7%	+1.7%	-2.1%	-3.0%	-6.0%
Apr 9	Mizuho	Maintains	Outperform → Outperform	—	$330.66	$329.99	-0.2%	+2.9%	+3.6%	+4.3%	+5.4%	+1.5%
Mar 5	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$306.49	$309.29	+0.9%	+1.8%	+5.7%	+6.8%	+8.7%	+6.0%
Mar 3	Mizuho	Maintains	Outperform → Outperform	—	$301.12	$302.81	+0.6%	+0.6%	+1.8%	+3.6%	+7.5%	+8.7%
Feb 19	Truist	Maintains	Buy → Buy	—	$268.56	$268.60	+0.0%	+6.8%	+8.5%	+5.7%	+7.0%	+13.9%
Feb 7	Barclays	Maintains	Equal Weight → Equal Weight	—	$285.01	$286.30	+0.5%	-0.4%	+0.5%	-4.2%	-6.5%	-5.0%
Feb 7	UBS	Maintains	Neutral → Neutral	—	$285.01	$286.30	+0.5%	-0.4%	+0.5%	-4.2%	-6.5%	-5.0%
Feb 6	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$317.01	$287.09	-9.4%	-10.1%	-10.4%	-9.6%	-13.9%	-15.9%

Recent Filings

8-K

Molina Healthcare, Inc. -- 8-K Filing

Molina Healthcare reaffirmed its full-year 2026 premium revenue and adjusted earnings guidance despite first quarter results, indicating management confidence in sustained operational performance.

Apr 22

8-K · 7.01 ! Medium

Molina Healthcare, Inc. -- 8-K 7.01: Regulation FD Disclosure

Molina Healthcare will reaffirm its 2026 guidance of at least $3.20 GAAP diluted EPS and $5.00 adjusted diluted EPS during upcoming investor meetings and the TD Cowen Health Care Conference.

Feb 26

8-K · 1.01 ! Medium

Molina Healthcare, Inc. -- 8-K 1.01: Financing / Debt Agreement

Molina Healthcare amended its credit agreement, likely modifying borrowing terms or covenants to provide greater financial flexibility for operations and potential strategic initiatives.

Feb 6

8-K

Molina Healthcare, Inc. -- 8-K Filing

Molina Healthcare reported a fourth quarter 2025 GAAP loss per diluted share of $3, while providing 2026 revenue and earnings guidance to investors.

Feb 5

Data updated apr 26, 2026 12:59pm · Source: massive.com